Sharma, A.; Bahl, A.; Frazer, R.; Godhania, E.; Halfpenny, N.; Hartl, K.; Heldt, D.; McGrane, J.; Şahbaz Gülser, S.; Venugopal, B.;
et al. Axitinib after Treatment Failure with Sunitinib or Cytokines in Advanced Renal Cell Carcinoma—Systematic Literature Review of Clinical and Real-World Evidence. Cancers 2024, 16, 2706.
https://doi.org/10.3390/cancers16152706
AMA Style
Sharma A, Bahl A, Frazer R, Godhania E, Halfpenny N, Hartl K, Heldt D, McGrane J, Şahbaz Gülser S, Venugopal B,
et al. Axitinib after Treatment Failure with Sunitinib or Cytokines in Advanced Renal Cell Carcinoma—Systematic Literature Review of Clinical and Real-World Evidence. Cancers. 2024; 16(15):2706.
https://doi.org/10.3390/cancers16152706
Chicago/Turabian Style
Sharma, Anand, Amit Bahl, Ricky Frazer, Esha Godhania, Nicholas Halfpenny, Kristina Hartl, Dorothea Heldt, John McGrane, Sera Şahbaz Gülser, Balaji Venugopal,
and et al. 2024. "Axitinib after Treatment Failure with Sunitinib or Cytokines in Advanced Renal Cell Carcinoma—Systematic Literature Review of Clinical and Real-World Evidence" Cancers 16, no. 15: 2706.
https://doi.org/10.3390/cancers16152706
APA Style
Sharma, A., Bahl, A., Frazer, R., Godhania, E., Halfpenny, N., Hartl, K., Heldt, D., McGrane, J., Şahbaz Gülser, S., Venugopal, B., Ritchie, A., & Crichton, K.
(2024). Axitinib after Treatment Failure with Sunitinib or Cytokines in Advanced Renal Cell Carcinoma—Systematic Literature Review of Clinical and Real-World Evidence. Cancers, 16(15), 2706.
https://doi.org/10.3390/cancers16152706
